West Pharmaceutical (WST) | Stock Overview & Key Data
West Pharmaceutical Performance Comparison
Stock Range
Today's Range
Low: $245.03
High: $250.18
on August 15, 2025
52 Week Range
Low: $187.43
High: $352.33
on April 9, 2025
on October 24, 2024
All-Time High: $475.35 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$17.7B
EPS
6.67
P/E Ratio (TTM)
36.91
Forward P/E
32.74
P/B Ratio
6.04
PEG Ratio
1.87
Div. Yield
0.38%
ROE
17.72%
Beta
1.049
Debt to Equity
10.52
Financial Highlights
Profitability
Gross Margin
35.73%
Operating Margin
20.87%
Profit Margin
16.48%
Returns and Earnings
Return on Assets (TTM)
10.53%
Return on Equity (TTM)
17.72%
EBITDA
$798.8M
Net Income (TTM)
$487.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$40.94
Quarterly Revenue Growth (YoY)
9.20%
Quarterly Earnings Growth (YoY)
18.40%
Dividend Information
Last 12-Month Dividend
$0.83
Current Dividend Yield
0.38%
3-Year Average Dividend Yield
0.07%
3-Year Average Annual Dividend
$0.79
3-Year Total Dividends
$2.37
Ex-Dividend Date
April 30, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical WST | 17.70B Large-cap | 2.17% | 11.38% | 16.86% | 16.68% | -25.03% | -18.05% | -22.95% | -9.31% |
| Intuitive Surgical ISRG | 172.16B Large-cap | 2.17% | -6.24% | -14.28% | -20.08% | -8.35% | 0.27% | 113.66% | 107.64% |
| Becton, Dickinson BDX | 56.16B Large-cap | 1.26% | 9.89% | 13.74% | -12.97% | -13.49% | -17.09% | -25.93% | -22.07% |
| Alcon ALC | 45.84B Large-cap | 2.29% | 2.05% | 0.05% | -1.95% | 5.10% | -7.32% | 27.36% | 49.65% |
| ResMed RMD | 41.71B Large-cap | 0.35% | 13.05% | 14.61% | 23.55% | 24.69% | 25.09% | 22.01% | 58.83% |
| Hologic HOLX | 15.08B Large-cap | -0.37% | 7.19% | 21.65% | 6.07% | -5.48% | -16.78% | -5.11% | 1.59% |
Ownership & Short Interest
Insider Ownership
0.61%
Institutional Ownership
98.26%
Shares Short
2M
Short Ratio
2.62
Short % of Shares Outstanding
3.96%
Average 10-Day Volume
541K
Average 90-Day Volume
763K
West Pharmaceutical Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in West Pharmaceutical would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is WST's 52-week high and low?
- In the last 52 weeks, West Pharmaceutical reached a high of $352.33 (on October 24, 2024) and a low of $187.43 (on April 9, 2025).
- What is the market cap and P/E ratio for WST?
- Curious about West Pharmaceutical's size and valuation? Its market capitalization stands at 17.70B. When it comes to valuation, the P/E ratio (trailing twelve months) is 36.91, and the forward P/E (looking ahead) is 32.74.
- Does WST pay dividends? If so, what's the yield?
- Yes, West Pharmaceutical is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.38%, and the company has paid an average of $0.79 per share annually over the past 3 years.
- Who are West Pharmaceutical's main competitors or similar companies to consider before investing?
When looking at West Pharmaceutical, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG172.16B Healthcare Medical Instruments & Supplies 0.27% 113.66% Becton, Dickinson
BDX56.16B Healthcare Medical Instruments & Supplies -17.09% -25.93% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -7.32% 27.36% ResMed
RMD41.71B Healthcare Medical Instruments & Supplies 25.09% 22.01% Hologic
HOLX15.08B Healthcare Medical Instruments & Supplies -16.78% -5.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for West Pharmaceutical Services Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of West Pharmaceutical's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.72%, the Debt to Equity ratio from the most recent quarter is 10.52, and its Gross Profit Margin stands at 35.73%.
- What is the recent revenue and earnings growth for WST?
- Looking at West Pharmaceutical's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.20%, and quarterly earnings saw a YoY growth of 18.40%.
- How much of WST stock is held by insiders and institutions?
- Wondering who owns West Pharmaceutical stock? Company insiders (like executives and directors) hold about 0.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 98.26%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.